Home All News

All News

Internet And Biotech Related News

Adding Immix Biopharma (IMMX) to 2022 Biotech 12 Pack List.

Added to 12 Biotech Stocks we Expect to Double List. The Original Biotech 6-Pack from 2020, is Growing to...
Roland Rick Perry

Tax Loss Selling Bargain? Adding Aditxt (ADTX).

Adding Aditxt (ADTX) to the upcoming "2022 Biotech 6-Pack, Stocks We Expect to Double" Watch List.

Dalrada (DFCO). Our 11th and Latest Ten Bagger.

We've actually had many more than 11 ten-baggers, as we report on companies which aren't clients. This is our 11th client we...
VYRE Network

Report: VYRE Network (CAPV).

Update Report: Our First Internet Play in Ages, and It’s a Doozy. Reporting from the Great City...

The Race to Develop Therapeutics for COVID. The Small Caps Fight for a Treatment...

The Second Wave: Biopharma Players Race to Develop Therapeutics for COVID-19 (BioSPace) December 21. Revive Therapeutics (RVTTF), RedHill BioPharma...

News and Charts on Four Small Cap Telehealth and Remote Health Monitoring Plays.

After Losing $33 Billion in Value, Teladoc Health Snags an Upgrade. With chances building...

Reuniting With the Affable Mr. Greg Halpern, 19 Years Later…

A Potential Christmas Present Arrives in our lap Early, From the Inventor of Crowdfunding and Winner of Incubator of The Year in...
VYRE

VYRE Streaming Network Partners with UNIFD.

With Clients Like McDonald's, Budweiser, CBS Sports, Norton and Intuit-TurboTax, "UNIFD is the Largest Independent Audio & Connected TV Marketplace, Period."
VYRE Network

VYRE Network (CAPV) Now Integrated With Samsung TV

Las Vegas, Nevada--(Newsfile Corp. - December 10, 2021) - VYRE Network (OTC Pink: CAPV) (a wholly-owned Cabo Verde Capital company, "VYRE") is pleased to announce that...
CPRE Networks

Adding VYRE Network (CAPV) to the Watch List.

Look What We Found. Our First Internet Play in Ages, And It's a Doozy. We would categorize this...

Latest article

Revive therapeutics

Our Best Risk to Reward Idea Ever?

Adding Revive Therapeutics (RVVTF, RVV.CN) to the "2022, Biotech 12 pack, 12 Biotech Stocks We Expect to...
Immunix Bio

ImmixBio (IMMX) Announces Positive Clinical Trial Safety Data.

Demonstrates 100% Completion of Planned Treatment Cycles. Immix Biopharma, Inc. Wed, January 19, 2022. ImmixBio...
Fuqua Professor David Ridley

Everything You Need to Know About FDA’s Priority Review Vouchers Worth $100’s of Millions.

Never Heard of These 'PRV's' but What a Potential Bonanza for the Recipients. They're transferable - as in they can be...